应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
未开盘 01-21 16:08:06
4.450
+0.040
+0.91%
最高
4.500
最低
4.410
成交量
3,696万
今开
4.470
昨收
4.410
日振幅
2.04%
总市值
517.89亿
流通市值
517.89亿
总股本
116.38亿
成交额
1.64亿
换手率
0.32%
流通股本
116.38亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
石药集团01月21日主力资金流出245万元 连续5日减仓
市场透视 · 01-21 16:16
石药集团01月21日主力资金流出245万元 连续5日减仓
离职石药之后,刘勇军出任华普生物董事长
医药魔方Invest · 01-21 09:47
离职石药之后,刘勇军出任华普生物董事长
石药集团瑞戈非尼片获药监局药品注册批件
财中社 · 01-20 18:35
石药集团瑞戈非尼片获药监局药品注册批件
石药集团(01093):瑞戈非尼片获药品注册批件
智通财经 · 01-20 18:17
石药集团(01093):瑞戈非尼片获药品注册批件
石药集团(01093)出现大手卖出81万股,成交价$4.46,涉资361.26万
阿斯达克财经 · 01-20 14:07
石药集团(01093)出现大手卖出81万股,成交价$4.46,涉资361.26万
石药集团子公司净利润下降超80%,创新药光环能否拯救公司未来?
阿尔法工场 · 01-20 12:46
石药集团子公司净利润下降超80%,创新药光环能否拯救公司未来?
新诺威:拟发行股份及支付现金购买石药百克100%股权并募集配套资金
金融界 · 01-20 08:13
新诺威:拟发行股份及支付现金购买石药百克100%股权并募集配套资金
石药集团(01093.HK)附属石药创新预警全年净利大减85%-90%
阿斯达克财经 · 01-19 20:14
石药集团(01093.HK)附属石药创新预警全年净利大减85%-90%
重磅降脂药恒瑞获批!信达、康方、君实之后,齐鲁、石药等全面参战
医药经济报 · 01-18
重磅降脂药恒瑞获批!信达、康方、君实之后,齐鲁、石药等全面参战
石药集团(01093):石药创新(300765.SZ)预期2024年归母净利为4500万-6600万元,同比下降84.81%–89.64%
智通财经 · 01-17
石药集团(01093):石药创新(300765.SZ)预期2024年归母净利为4500万-6600万元,同比下降84.81%–89.64%
【市场】石药集团抢攻5亿大品种
米内网 · 01-17
【市场】石药集团抢攻5亿大品种
石药集团01月17日主力资金流出854万元 连续3日减仓
市场透视 · 01-17
石药集团01月17日主力资金流出854万元 连续3日减仓
石药银湖公司荣获“国家级绿色工厂”称号
石药集团 · 01-17
石药银湖公司荣获“国家级绿色工厂”称号
金十数据整理:每日港股市场要闻速递(1月17日 周五)
美港电讯 · 01-17
金十数据整理:每日港股市场要闻速递(1月17日 周五)
石药集团(01093):SYS 6043(抗体偶联药物)获美国临床试验批准
智通财经 · 01-16
石药集团(01093):SYS 6043(抗体偶联药物)获美国临床试验批准
石药集团01月16日遭主力抛售1947万元 环比增加145.52%
市场透视 · 01-16
石药集团01月16日遭主力抛售1947万元 环比增加145.52%
鞍石药业(宁波)有限责任公司药品申请临床试验默示许可获受理
金融界 · 01-15
鞍石药业(宁波)有限责任公司药品申请临床试验默示许可获受理
【关注】石药拿下重磅1类新药,600亿市场掀波澜
米内网 · 01-14
【关注】石药拿下重磅1类新药,600亿市场掀波澜
丽珠集团终止PD-1项目损失1.75亿元,石药集团1类新药获批上市,药明康德出售股票获益超20亿元
谈医说药 · 01-13
丽珠集团终止PD-1项目损失1.75亿元,石药集团1类新药获批上市,药明康德出售股票获益超20亿元
石药集团新药普卢格列汀片获批上市
财中社 · 01-13
石药集团新药普卢格列汀片获批上市
加载更多
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":4.45,"timestamp":1737446886011,"preClose":4.41,"halted":0,"volume":36960417,"delay":0,"floatShares":11638000000,"shares":11638000000,"eps":0.5291407286273412,"marketStatus":"未开盘","change":0.04,"latestTime":"01-21 16:08:06","open":4.47,"high":4.5,"low":4.41,"amount":164304302,"amplitude":0.020408,"askPrice":4.45,"askSize":2978000,"bidPrice":4.44,"bidSize":202000,"shortable":3,"etf":0,"ttmEps":0.46702068800236546,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1737509400000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":4.41,"dividendRate":0.064454,"openAndCloseTimeList":[[1737423000000,1737432000000],[1737435600000,1737446400000]],"volumeRatio":0.725922,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1737907200000,"strike":"4.40","timestamp":1737424100286,"price":0.1,"volume":500,"amount":100000,"type":"*"},{"symbol":"CSP.HK","call":false,"expireDate":1737907200000,"strike":"4.50","timestamp":1737424057141,"price":0.12,"volume":334,"amount":80160,"type":"+"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.3475,"impliedVolPercentile":0.4737},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2505217483","title":"石药集团01月21日主力资金流出245万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2505217483","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505217483?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:16","pubTimestamp":1737447376,"startTime":"0","endTime":"0","summary":"01月21日, 石药集团股价涨0.91%,报收4.45元,成交金额1.64亿元,换手率0.32%,振幅2.04%,量比0.72。石药集团今日主力资金净流出245万元,连续5日净流出,上一交易日主力净流出1613万元。该股近5个交易日上涨1.83%,主力资金累计净流出5449万元;近20日主力资金累计净流出3194万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161632a229ea1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161632a229ea1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU0140636845.USD","IE00B543WZ88.USD","BK1191","IE0008368742.USD","LU0880133367.SGD","IE0008369823.USD","01093","IE00B031HY20.USD","LU0067412154.USD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1226287529.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU1226288170.HKD","LU1008478684.HKD","LU1960683339.HKD","LU0501845795.SGD","LU1226287792.SGD","LU1226287875.USD","BK1521","LU0326950275.SGD","LU1807302812.USD","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1152091168.USD","BK1515"],"gpt_icon":0},{"id":"2505078269","title":"离职石药之后,刘勇军出任华普生物董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2505078269","media":"医药魔方Invest","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505078269?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:47","pubTimestamp":1737424052,"startTime":"0","endTime":"0","summary":"据企查查APP,近日,华普生物技术(河北)股份有限公司发生职务变更:刘勇军出任董事长一职。图片来源:企查查2024年8月,刘勇军离开信达生物,随后,9月5日,石药集团宣布聘任刘勇军为集团执行总裁、全球研发总裁,但履新不到三月后,刘勇军再次离任。华普生物官网显示,刘勇军为其科学创始人之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121095023a2298a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121095023a2298a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1226287529.USD","SG9999004220.SGD","IE0008369823.USD","BK1515","LU1152091754.HKD","BK1521","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00BZ08YT58.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU1152091168.USD","LU1951186391.HKD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226287792.SGD","LU1008478684.HKD","01093","LU1226287875.USD","LU1226288253.USD","LU1960683339.HKD","LU0072913022.USD","LU0067412154.USD","LU1807302812.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","LU1226288170.HKD"],"gpt_icon":0},{"id":"2504403183","title":"石药集团瑞戈非尼片获药监局药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2504403183","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504403183?lang=zh_cn&edition=full","pubTime":"2025-01-20 18:35","pubTimestamp":1737369304,"startTime":"0","endTime":"0","summary":"财中社1月20日电石药集团(01093)发布公告,本集团开发的瑞戈非尼片(40mg)已获得中华人民共和国国家药品监督管理局颁发的药品注册批件,并视同通过仿制药质量和疗效一致性评价。瑞戈非尼是一种小分子口服多靶点激酶抑制剂,适用于多种癌症患者,包括转移性结直肠癌、局部晚期胃肠道间质瘤和肝细胞癌患者。该产品的获批将进一步丰富公司的抗肿瘤领域产品线,增强公司的市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501203302301997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0008369823.USD","LU1152091754.HKD","LU1152091168.USD","IE0008368742.USD","LU0326950275.SGD","BK1521","01093","IE00B031HY20.USD","LU1226287792.SGD","LU0501845795.SGD","LU1008478684.HKD","LU1226287529.USD","LU1807302812.USD","BK1515","LU1993786604.SGD","BK1191","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","IE00BZ08YT58.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1951186391.HKD","SG9999004220.SGD","LU0140636845.USD","LU0067412154.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1226287875.USD","LU1960683339.HKD"],"gpt_icon":0},{"id":"2504847702","title":"石药集团(01093):瑞戈非尼片获药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2504847702","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504847702?lang=zh_cn&edition=full","pubTime":"2025-01-20 18:17","pubTimestamp":1737368232,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的瑞戈非尼片已获得中华人民共和国国家药品监督管理局颁发的药品注册批件,并视同通过仿制药质量和疗效一致性评价。该产品的获批将进一步丰富集团在抗肿瘤领域的产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0140636845.USD","LU1960683339.HKD","LU1226287792.SGD","LU1152091754.HKD","LU1951186391.HKD","LU0072913022.USD","BK1515","LU0880133367.SGD","IE00B031HY20.USD","LU1226288253.USD","LU0067412154.USD","LU1152091168.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","BK1521","01093","IE00BZ08YT58.USD","LU1226287529.USD","BK1191","IE0008369823.USD","LU1807302812.USD","LU1993786604.SGD","LU1008478684.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","IE0008368742.USD","LU1226288170.HKD","IE00BZ08YR35.GBP","LU0326950275.SGD","SG9999004220.SGD","LU0501845795.SGD"],"gpt_icon":0},{"id":"2504426652","title":"石药集团(01093)出现大手卖出81万股,成交价$4.46,涉资361.26万","url":"https://stock-news.laohu8.com/highlight/detail?id=2504426652","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504426652?lang=zh_cn&edition=full","pubTime":"2025-01-20 14:07","pubTimestamp":1737353220,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在下午02:07出现大手卖出,成交量为81万,成交价为港币$4.46,涉资361.26万。至目前为止,股价升1.591%,今日最高价为$4.54,而最低价为$4.43,总成交量为4.442千万股,总成交金额港币$1.992亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2501206253/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE0008368742.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0067412154.USD","LU1951186391.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0072913022.USD","IE0008369823.USD","LU0140636845.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","01093","LU1226287875.USD","LU1226287529.USD","LU1226288253.USD","BK1515","IE00BZ08YT58.USD","LU1807302812.USD","IE00B031HY20.USD","BK1521","LU1152091754.HKD","LU0326950275.SGD","LU1152091168.USD","LU1960683339.HKD","LU1226287792.SGD","BK1191","SG9999004220.SGD"],"gpt_icon":0},{"id":"2504423282","title":"石药集团子公司净利润下降超80%,创新药光环能否拯救公司未来?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504423282","media":"阿尔法工场","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504423282?lang=zh_cn&edition=full","pubTime":"2025-01-20 12:46","pubTimestamp":1737348410,"startTime":"0","endTime":"0","summary":"近日,石药创新制药股份有限公司发布了截至 2024 年 12 月 31 日的年度业绩预告。公告显示,公司预计归属于上市公司股东的净利润为 4500 万元至 6600 万元,同比下降 84.81%至 89.64%;扣除非经常性损益后的净利润预计为 3800 万元至 5600 万元,同比下降 92.47%至 94.89%。这显示了公司在 创新药 领域的积极布局和强大的研发实力,为未来的业绩增长奠定了基础。石药集团 作为其母公司,也需在资源整合、战略规划等方面给予支持,助力石药创新在创新药领域取得更好的发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120125809abb14f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120125809abb14f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","06978"],"gpt_icon":0},{"id":"2504411625","title":"新诺威:拟发行股份及支付现金购买石药百克100%股权并募集配套资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2504411625","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504411625?lang=zh_cn&edition=full","pubTime":"2025-01-20 08:13","pubTimestamp":1737331983,"startTime":"0","endTime":"0","summary":"金融界1月20日消息,新诺威公告称,公司拟通过发行股份及支付现金方式购买维生药业、石药上海、恩必普药业合计持有的石药百克100%股权,其中以发行股份、现金方式支付对价的比例占交易对价的比例分别为90%、10%,股份支付对价金额为684,000.00万元,现金支付对价金额为76,000.00万元。本次交易完成后,上市公司将持有石药百克100%股权。同时,公司拟向不超过35名符合条件的特定对象发行股份募集配套资金,总额不超过178,000.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120081444a2281562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120081444a2281562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287875.USD","LU1226288170.HKD","BK1515","BK1521","LU1152091754.HKD","01093","LU1807302812.USD","LU0501845795.SGD","LU0072913022.USD","IE00BZ08YS42.EUR","LU1993786604.SGD","IE0008369823.USD","LU1960683339.HKD","LU0067412154.USD","IE00B5MMRT66.SGD","LU0880133367.SGD","IE0008368742.USD","SG9999004220.SGD","LU1008478684.HKD","LU1951186391.HKD","BK1191","LU1226287529.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","IE00BZ08YT58.USD","LU1226288253.USD","IE00B543WZ88.USD","LU1152091168.USD","LU0140636845.USD","LU0326950275.SGD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2504213466","title":"石药集团(01093.HK)附属石药创新预警全年净利大减85%-90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504213466","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504213466?lang=zh_cn&edition=full","pubTime":"2025-01-19 20:14","pubTimestamp":1737288840,"startTime":"0","endTime":"0","summary":"石药集团公布,附属石药创新发盈警,预计2024年度归属股东净利润介乎4,500万至6,600万人民币,较上年度倒退84.8%-89.6%。原因是公司功能性原料业务因咖啡因价格回落,收入有所下降;及多款在研产品取得重要进展,研发费用投入加大。(港股报价延迟最少十五分钟。沽空资料截至 2025-01-17 16:25。)过往派息公布日期派息事项派息内容2024/11/15第三季业绩无派息2024/08/21中期业绩股息:港元 0.16002024/05/27第一季业绩无派息2024/03/20末期业绩股息:港元 0.1400AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230531121547900_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230531121547900_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411554/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1152091754.HKD","LU0880133367.SGD","IE00B031HY20.USD","IE00B5MMRT66.SGD","BK1515","SG9999004220.SGD","IE00BZ08YT58.USD","LU0067412154.USD","LU1226287529.USD","BK1191","LU0326950275.SGD","LU1008478684.HKD","LU1152091168.USD","BK1521","01093","LU1226287875.USD","LU1993786604.SGD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1226288170.HKD","LU0072913022.USD","LU0140636845.USD","LU1960683339.HKD","IE0008369823.USD","LU1951186391.HKD","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU1807302812.USD","LU0501845795.SGD"],"gpt_icon":0},{"id":"2504702311","title":"重磅降脂药恒瑞获批!信达、康方、君实之后,齐鲁、石药等全面参战","url":"https://stock-news.laohu8.com/highlight/detail?id=2504702311","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504702311?lang=zh_cn&edition=full","pubTime":"2025-01-18 20:13","pubTimestamp":1737202395,"startTime":"0","endTime":"0","summary":"据悉,英克司兰钠在2020年获批后逐年保持销售额高增长,在2023年大涨217%至3.55亿美元。此前,信达生物、康方生物、君实生物三家企业共同成为国内PCSK9赛道的主力选手,恒瑞医药此番加入第一梯队的行列,全新的市场格局正在初步形成。除此之外,还有齐鲁制药、圣因生物、石药集团、天广实等众多企业紧随其后,未来的市场竞争“白热化”在所难免。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118201515a226ad8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118201515a226ad8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1951186391.HKD","LU0880133367.SGD","LU0501845795.SGD","LU1226288170.HKD","BK1521","IE00B543WZ88.USD","LU0140636845.USD","LU0072913022.USD","IE0008369823.USD","IE00B031HY20.USD","BK1191","LU1008478684.HKD","LU0067412154.USD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1152091168.USD","LU1226287792.SGD","LU1226287529.USD","LU1993786604.SGD","LU1152091754.HKD","01093","LU1226287875.USD","IE00BZ08YS42.EUR","LU1807302812.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE0008368742.USD","BK1515","LU0326950275.SGD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2504784159","title":"石药集团(01093):石药创新(300765.SZ)预期2024年归母净利为4500万-6600万元,同比下降84.81%–89.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504784159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504784159?lang=zh_cn&edition=full","pubTime":"2025-01-17 19:53","pubTimestamp":1737114831,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 公布,石药创新预期2024年归属于上市公司股东的净利润为4500万-6600万元,同比下降84.81%–89.64%;预期扣除非经常性损益的净利润为3800万-5600万元,同比下降92.47%–94.89%。报告期内,石药创新持续加大研发创新投入,全年研发费用约8.4亿元,较上年增长约1.7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B031HY20.USD","300765","LU1226287875.USD","LU1993786604.SGD","LU1152091754.HKD","LU0072913022.USD","BK1515","BK0226","LU1226287529.USD","LU1226287792.SGD","LU0326950275.SGD","BK1191","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","01093","LU1226288170.HKD","IE0008368742.USD","LU1008478684.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1960683339.HKD","LU0501845795.SGD","IE00BZ08YT58.USD","BK1521","LU1807302812.USD","LU1152091168.USD","LU0880133367.SGD","IE0008369823.USD","LU1226288253.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"2504156910","title":"【市场】石药集团抢攻5亿大品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2504156910","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504156910?lang=zh_cn&edition=full","pubTime":"2025-01-17 17:06","pubTimestamp":1737104781,"startTime":"0","endTime":"0","summary":"精彩内容1月17日,CDE官网显示,石药集团子公司石药银湖的3类仿制药吡拉西坦注射液上市申请获得承办。吡拉西坦注射液为脑代谢改善药,2023年在中国公立医疗机构终端销售额超过5亿元。吡拉西坦注射液属于神经系统疾病药物,适用于急慢性脑血管病、脑外伤、各种中毒性脑病等多种原因所致的记忆减退及轻、中度脑功能障碍,也可用于儿童智能发育迟缓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117185705abae75a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117185705abae75a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU1951186391.HKD","LU1152091754.HKD","LU1226287529.USD","LU0880133367.SGD","SG9999004220.SGD","LU0140636845.USD","BK1515","IE00BZ08YT58.USD","01093","IE00BZ08YR35.GBP","LU0072913022.USD","BK1191","LU1008478684.HKD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1226287875.USD","BK1521","LU0326950275.SGD","LU1807302812.USD","IE00B031HY20.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","IE0008369823.USD","LU0501845795.SGD","IE0008368742.USD","LU0067412154.USD","LU1960683339.HKD","LU1226287792.SGD","LU1993786604.SGD"],"gpt_icon":0},{"id":"2504314131","title":"石药集团01月17日主力资金流出854万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2504314131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504314131?lang=zh_cn&edition=full","pubTime":"2025-01-17 16:16","pubTimestamp":1737101803,"startTime":"0","endTime":"0","summary":"01月17日,石药集团股价收平报4.40元,成交金额2.24亿元,换手率0.44%,振幅1.82%,量比0.97。石药集团今日主力资金净流出854万元,连续3日净流出,上一交易日主力净流出1947万元,今日环比减少56.14%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为27.27%,平均跌幅为0.74%。该股近5个交易日上涨1.14%,主力资金累计净流出334万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入9620万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117161826abae4573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117161826abae4573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","01093","LU0140636845.USD","LU1226287875.USD","LU1226287792.SGD","LU0072913022.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","LU0501845795.SGD","LU1226288170.HKD","LU1152091754.HKD","IE00B543WZ88.USD","LU1951186391.HKD","LU1960683339.HKD","LU1993786604.SGD","LU1226287529.USD","IE00B031HY20.USD","SG9999004220.SGD","LU1807302812.USD","LU0326950275.SGD","IE0008368742.USD","BK1515","BK1521","IE00BZ08YS42.EUR","LU0880133367.SGD","LU0067412154.USD","LU1152091168.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1191"],"gpt_icon":0},{"id":"2504831951","title":"石药银湖公司荣获“国家级绿色工厂”称号","url":"https://stock-news.laohu8.com/highlight/detail?id=2504831951","media":"石药集团","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504831951?lang=zh_cn&edition=full","pubTime":"2025-01-17 13:51","pubTimestamp":1737093060,"startTime":"0","endTime":"0","summary":"石药银湖制药有限公司凭借在绿色制造和管理方面的卓越实力,以及在可持续发展领域的突出表现,继荣获“山西省绿色工厂”称号后,再度脱颖而出,成功跻身“国家级绿色工厂”行列。本次公示的“2024年度绿色制造名单”涵盖了绿色工厂、绿色工业园区和绿色供应链管理企业。其中,绿色工厂是指实现用地集约化、原料无害化、生产洁净化、废物资源化、能源低碳化的企业,是绿色制造核心实施单元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-17/doc-inefhewz5315237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0880133367.SGD","BK1515","LU1152091754.HKD","IE00BZ08YT58.USD","01093","LU1807302812.USD","BK1521","BK1191","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0140636845.USD","IE00B543WZ88.USD","SG9999004220.SGD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","LU1960683339.HKD","LU0072913022.USD","LU1951186391.HKD","LU1008478684.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","IE0008368742.USD","LU0501845795.SGD","LU1993786604.SGD","LU0067412154.USD","LU0326950275.SGD","LU1226288170.HKD"],"gpt_icon":0},{"id":"2504997532","title":"金十数据整理:每日港股市场要闻速递(1月17日 周五)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504997532","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504997532?lang=zh_cn&edition=full","pubTime":"2025-01-17 09:08","pubTimestamp":1737076119,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688331","LU0516422952.EUR","HTCD.SI","LU1688375341.USD","YANG","LU0633140727.USD","SG9999001903.USD","LU2362541513.USD","02202","601899","LU2242644610.SGD","00590","000408","LU0531970944.HKD","00813","LU0708995583.HKD","02601","000002","02136","09995","LU0359201612.USD","LU0127658192.USD","SGXZ49509284.SGD","02899","HSCEI","IE00B0169L03.USD","01357","601601","601888","03347","TCEHY","LU1323998911.USD","03333","07226","LU0348825331.USD","01880","LU1303224171.USD","LU0786609619.USD","LU1568876251.USD","LU1196710351.USD","00136","BK0040","01801","80700","LU0605514214.HKD","LU1282649141.HKD","01093","LU0463099449.HKD","06666","00700"],"gpt_icon":0},{"id":"2503572789","title":"石药集团(01093):SYS 6043(抗体偶联药物)获美国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2503572789","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503572789?lang=zh_cn&edition=full","pubTime":"2025-01-16 17:05","pubTimestamp":1737018353,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的SYS 6043的试验性新药申请已获美国食品药品监督管理局批准,可以在美国开展临床试验。此前,该产品已经于2024年12月获得中华人民共和国国家药品监督管理局批准,可以在中国开展临床试验。本次获批临床的适应症为晚期╱转移性实体瘤,该产品预计适用于治疗小细胞肺癌、食管鳞癌、头颈鳞癌、前列腺癌、肝细胞癌等。该产品已在国内外提交多项专利申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1238692.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288253.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","BK1141","LU1807302812.USD","LU1152091168.USD","IE00B031HY20.USD","LU0880133367.SGD","BK1576","BK1583","BK1515","01093","LU0501845795.SGD","LU1226287529.USD","SG9999004220.SGD","IE0008368742.USD","BK1191","LU1960683339.HKD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU1226288170.HKD","BK1521","LU1008478684.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0072913022.USD","LU0140636845.USD","03347","LU0067412154.USD","LU1993786604.SGD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2503983549","title":"石药集团01月16日遭主力抛售1947万元 环比增加145.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503983549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503983549?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:16","pubTimestamp":1737015391,"startTime":"0","endTime":"0","summary":"01月16日, 石药集团股价涨1.38%,报收4.40元,成交金额1.67亿元,换手率0.33%,振幅3.00%,量比0.66。石药集团今日主力资金净流出1947万元,上一交易日主力净流出793万元,今日环比增加145.52%。该股近5个交易日下跌0.67%,主力资金累计净流出47万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入4900万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116161718abacec3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116161718abacec3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0501845795.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1226287875.USD","LU1152091168.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1226287529.USD","LU1960683339.HKD","BK1521","LU1993786604.SGD","LU1807302812.USD","LU1226288253.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","BK1191","IE0008369823.USD","IE00B543WZ88.USD","LU0067412154.USD","LU0880133367.SGD","IE0008368742.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","SG9999004220.SGD","LU1226288170.HKD","LU1152091754.HKD","LU0072913022.USD","BK1515","01093","LU0326950275.SGD"],"gpt_icon":0},{"id":"2503619267","title":"鞍石药业(宁波)有限责任公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2503619267","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503619267?lang=zh_cn&edition=full","pubTime":"2025-01-15 19:13","pubTimestamp":1736939608,"startTime":"0","endTime":"0","summary":"1月15日,据CDE官网消息,鞍石药业(宁波)有限责任公司联合申请药品“PLB1004胶囊”,获得临床试验默示许可,受理号CXHL2401225。公示信息显示,药品“PLB1004胶囊”适应症:PLB1004胶囊联合ANS014004片治疗经EGFR-TKI治疗失败后伴MET扩增或c-Met过表达的局部晚期或转移性非小细胞肺癌。鞍石药业(宁波)有限责任公司,成立于2024年,位于宁波市,是一家以从事医药制造业为主的企业。企业注册资本500万人民币。通过天眼查大数据分析,鞍石药业(宁波)有限责任公司。主要股东信息显示,鞍石药业(宁波)有限责任公司由北京鞍石生物科技股份有限公司持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/15191347485648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008368742.USD","IE00B031HY20.USD","BK1583","BK1191","BK1521","SG9999004220.SGD","LU0067412154.USD","LU1008478684.HKD","BK1141","LU1993786604.SGD","LU1226288170.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE0008369823.USD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU0072913022.USD","03347","LU1152091754.HKD","01093","BK1576","LU0326950275.SGD","LU0501845795.SGD","BK1515","LU1226288253.USD","LU0880133367.SGD","LU0140636845.USD","LU1960683339.HKD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1226287529.USD"],"gpt_icon":0},{"id":"2503801573","title":"【关注】石药拿下重磅1类新药,600亿市场掀波澜","url":"https://stock-news.laohu8.com/highlight/detail?id=2503801573","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503801573?lang=zh_cn&edition=full","pubTime":"2025-01-14 16:59","pubTimestamp":1736845186,"startTime":"0","endTime":"0","summary":"精彩内容1月13日,国家药监局官网显示,石药集团欧意药业申报的化药1类创新药普卢格列汀片获批上市。米内网数据显示,糖尿病用药在近年中国三大终端六大市场销售规模均超过600亿元,2024年上半年同比增长5.50%。不久前,石药集团发布公告,集团开发的1类新药SYS6041获批临床。普卢格列汀片是一种新型口服二肽基肽酶-IV抑制剂,适用于改善成人2型糖尿病患者的血糖控制。石药集团此前糖尿病用药批文情况来源:米内网中国上市药品数据库","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114172748abaa5ade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114172748abaa5ade&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","SG9999004220.SGD","LU1226287875.USD","LU0140636845.USD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","BK1515","LU1226288170.HKD","LU1152091754.HKD","IE0008368742.USD","LU1008478684.HKD","LU1993786604.SGD","BK1521","LU1226287529.USD","LU0326950275.SGD","LU1152091168.USD","BK1191","LU0067412154.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE0008369823.USD","LU1951186391.HKD","IE00B543WZ88.USD","LU0501845795.SGD","LU0072913022.USD","01093","LU1226288253.USD","LU0880133367.SGD","LU1960683339.HKD"],"gpt_icon":0},{"id":"2503821275","title":"丽珠集团终止PD-1项目损失1.75亿元,石药集团1类新药获批上市,药明康德出售股票获益超20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503821275","media":"谈医说药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503821275?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:46","pubTimestamp":1736783195,"startTime":"0","endTime":"0","summary":"公告显示,丽珠集团此次需计提资产减值损失金额共计1.75亿元,其中开发支出减值损失为9242.5万元,主要原因是结合国内竞品情况及未来市场预测等因素,经审慎考量,为合理配置资源,更好地聚焦优势项目,公司决定终止PD-1项目。此次计提资产减值准备将减少公司2024年度归属于母公司股东的净利润1.06亿元。公开资料资料显示,上述PD-1项目开发历时超过8年。截至公告披露日,累计投入的研发费用为人民币2094.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113235007a220528e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113235007a220528e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","IE00BZ08YS42.EUR","LU0708995583.HKD","LU0326950275.SGD","BK1141","LU1807302812.USD","LU1152091168.USD","IE00B031HY20.USD","LU2045819591.USD","LU0880133367.SGD","BK1576","LU0052750758.USD","LU0320764599.SGD","BK1583","BK1515","01093","LU0501845795.SGD","LU1226287529.USD","SG9999004220.SGD","IE0008368742.USD","BK1191","LU1960683339.HKD","LU1046422090.SGD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU2125910500.SGD","LU1226288170.HKD","BK1521","LU1008478684.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","02359","LU1951186391.HKD","LU0072913022.USD","LU0140636845.USD","LU0067412154.USD","LU1993786604.SGD","LU2242644610.SGD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2503750733","title":"石药集团新药普卢格列汀片获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2503750733","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503750733?lang=zh_cn&edition=full","pubTime":"2025-01-13 17:38","pubTimestamp":1736761118,"startTime":"0","endTime":"0","summary":"财中社1月13日电石药集团(01093)发布公告,本集团开发的化学药品1类新药普卢格列汀片(商品名:善泽平)已获国家药品监督管理局批准上市。该产品为一种新型口服二肽基肽酶-IV(DPP-4)抑制剂,具有高选择性和强抑制性,能够有效降低血糖水平,适用于改善成人2型糖尿病患者的血糖控制。支持该产品获批的两项关键Ⅲ期临床试验结果显示,其具有持久的降糖作用且不易诱发低血糖和增加体重。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501133295324727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0326950275.SGD","LU0501845795.SGD","01093","LU1008478684.HKD","BK1515","LU1226288170.HKD","LU0067412154.USD","LU1993786604.SGD","IE0008368742.USD","LU0072913022.USD","LU0880133367.SGD","LU1152091168.USD","LU1226288253.USD","IE00B031HY20.USD","LU1226287529.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","SG9999004220.SGD","LU1152091754.HKD","LU1807302812.USD","BK1521","BK1191","IE00B543WZ88.USD","IE0008369823.USD","LU1960683339.HKD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226287875.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":-0.0748},{"period":"3month","weight":-0.2826},{"period":"6month","weight":-0.2175},{"period":"1year","weight":-0.194},{"period":"ytd","weight":-0.069}],"compareEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":0.0196},{"period":"3month","weight":-0.0315},{"period":"6month","weight":0.1824},{"period":"1year","weight":0.3439},{"period":"ytd","weight":0.0023}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.005348},{"month":2,"riseRate":0.733333,"avgChangeRate":0.098085},{"month":3,"riseRate":0.466667,"avgChangeRate":0.019763},{"month":4,"riseRate":0.6,"avgChangeRate":0.056385},{"month":5,"riseRate":0.6,"avgChangeRate":0.038129},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004615},{"month":7,"riseRate":0.354839,"avgChangeRate":0.000119},{"month":8,"riseRate":0.419355,"avgChangeRate":0.009776},{"month":9,"riseRate":0.516129,"avgChangeRate":0.002662},{"month":10,"riseRate":0.580645,"avgChangeRate":0.016021},{"month":11,"riseRate":0.451613,"avgChangeRate":0.005451},{"month":12,"riseRate":0.483871,"avgChangeRate":-0.01556}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}